Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.

Di Giovanni G, Chagraoui A, Puginier E, Galati S, De Deurwaerdère P.

Neurobiol Dis. 2018 Aug 24. pii: S0969-9961(18)30485-6. doi: 10.1016/j.nbd.2018.08.014. [Epub ahead of print] Review.

PMID:
30149181
2.

Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Mestre-Francés N, Serratrice N, Gennetier A, Devau G, Cobo S, Trouche SG, Fontès P, Zussy C, De Deurwaerdere P, Salinas S, Mennechet FJ, Dusonchet J, Schneider BL, Saggio I, Kalatzis V, Luquin-Piudo MR, Verdier JM, Kremer EJ.

JCI Insight. 2018 Jul 25;3(14). pii: 98202. doi: 10.1172/jci.insight.98202. [Epub ahead of print]

3.

Alteration of nociceptive integration in the spinal cord of a rat model of Parkinson's disease.

Charles KA, Naudet F, Bouali-Benazzouz R, Landry M, De Deurwaerdère P, Fossat P, Benazzouz A.

Mov Disord. 2018 Jul;33(6):1010-1015. doi: 10.1002/mds.27377. Epub 2018 May 18.

PMID:
29774960
4.

Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion.

Sabbar M, Delaville C, De Deurwaerdère P, Lakhdar-Ghazal N, Benazzouz A.

Front Neurosci. 2018 Mar 19;12:173. doi: 10.3389/fnins.2018.00173. eCollection 2018.

5.

Inter-individual differences in the impulsive/compulsive dimension: deciphering related dopaminergic and serotonergic metabolisms at rest.

Dellu-Hagedorn F, Rivalan M, Fitoussi A, De Deurwaerdère P.

Philos Trans R Soc Lond B Biol Sci. 2018 Apr 19;373(1744). pii: 20170154. doi: 10.1098/rstb.2017.0154.

PMID:
29483340
6.

Preferential modulation of the lateral habenula activity by serotonin-2A rather than -2C receptors: Electrophysiological and neuroanatomical evidence.

Delicata F, Bombardi C, Pierucci M, Di Maio R, De Deurwaerdère P, Di Giovanni G.

CNS Neurosci Ther. 2018 Aug;24(8):721-733. doi: 10.1111/cns.12830. Epub 2018 Feb 25.

PMID:
29479825
7.

Does the Serotonin2C receptor segregate circuits of the basal ganglia responding to cingulate cortex stimulation?

Lagière M, Bosc M, Whitestone S, Manem J, Elboukhari H, Benazzouz A, Di Giovanni G, De Deurwaerdère P.

CNS Neurosci Ther. 2018 Aug;24(8):741-744. doi: 10.1111/cns.12777. Epub 2017 Nov 15. No abstract available.

PMID:
29143496
8.

TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?

Di Giovanni G, De Deurwaerdère P.

Neuropharmacology. 2017 Oct 4. pii: S0028-3908(17)30471-9. doi: 10.1016/j.neuropharm.2017.10.004. [Epub ahead of print] Review.

PMID:
28987938
9.

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications.

Miguelez C, Benazzouz A, Ugedo L, De Deurwaerdère P.

Front Cell Neurosci. 2017 Sep 12;11:274. doi: 10.3389/fncel.2017.00274. eCollection 2017. Review.

10.

Purposeless oral activity induced by meta-chlorophenylpiperazine (m-CPP): Undefined tic-like behaviors?

Kreiss DS, De Deurwaerdère P.

J Neurosci Methods. 2017 Dec 1;292:30-36. doi: 10.1016/j.jneumeth.2017.05.007. Epub 2017 May 5.

PMID:
28483714
11.

Neurobiology and neuropharmacology of monoaminergic systems.

De Deurwaerdère P, Ramsay RR, Di Giovanni G.

Prog Neurobiol. 2017 Apr;151:1-3. doi: 10.1016/j.pneurobio.2017.02.001. Epub 2017 Mar 2. No abstract available.

PMID:
28259728
12.

Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction.

Dellu-Hagedorn F, Fitoussi A, De Deurwaerdère P.

J Neurosci Methods. 2017 Mar 15;280:54-63. doi: 10.1016/j.jneumeth.2017.01.020. Epub 2017 Feb 1.

PMID:
28161298
13.

Cortico-subthalamic inputs from the motor, limbic, and associative areas in normal and dopamine-depleted rats are not fully segregated.

Janssen MLF, Temel Y, Delaville C, Zwartjes DGM, Heida T, De Deurwaerdère P, Visser-Vandewalle V, Benazzouz A.

Brain Struct Funct. 2017 Aug;222(6):2473-2485. doi: 10.1007/s00429-016-1351-5. Epub 2016 Dec 24.

PMID:
28013397
14.

Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine.

De Deurwaerdère P, Binda C, Corne R, Leone C, Valeri A, Valoti M, Ramsay RR, Fall Y, Marco-Contelles J.

ACS Chem Neurosci. 2017 May 17;8(5):1026-1035. doi: 10.1021/acschemneuro.6b00377. Epub 2016 Dec 30.

PMID:
27977122
15.

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Di Giovanni G, Svob Strac D, Sole M, Unzeta M, Tipton KF, Mück-Šeler D, Bolea I, Della Corte L, Nikolac Perkovic M, Pivac N, Smolders IJ, Stasiak A, Fogel WA, De Deurwaerdère P.

Front Neurosci. 2016 Nov 24;10:541. eCollection 2016. Review.

16.

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Svob Strac D, Pivac N, Smolders IJ, Fogel WA, De Deurwaerdere P, Di Giovanni G.

Front Neurosci. 2016 Nov 10;10:492. eCollection 2016. Review.

17.

Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.

De Deurwaerdère P, Di Giovanni G, Millan MJ.

Prog Neurobiol. 2017 Apr;151:57-100. doi: 10.1016/j.pneurobio.2016.07.002. Epub 2016 Jul 4. Review.

PMID:
27389773
18.

Updating neuropathology and neuropharmacology of monoaminergic systems.

Ramsay RR, De Deurwaerdère P, Di Giovanni G.

Br J Pharmacol. 2016 Jul;173(13):2065-8. doi: 10.1111/bph.13508.

19.

L-DOPA elicits non-vesicular releases of serotonin and dopamine in hemiparkinsonian rats in vivo.

Miguelez C, Navailles S, Delaville C, Marquis L, Lagière M, Benazzouz A, Ugedo L, De Deurwaerdère P.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1297-309. doi: 10.1016/j.euroneuro.2016.05.004. Epub 2016 May 24.

PMID:
27234917
20.

Cariprazine:New dopamine biased agonist for neuropsychiatric disorders.

De Deurwaerdère P.

Drugs Today (Barc). 2016 Feb;52(2):97-110. doi: 10.1358/dot.2016.52.2.2461868. Review.

PMID:
27092339
21.

Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications.

De Deurwaerdère P, Di Giovanni G.

Prog Neurobiol. 2017 Apr;151:175-236. doi: 10.1016/j.pneurobio.2016.03.004. Epub 2016 Mar 22. Review.

PMID:
27013075
22.

The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats.

Miguelez C, Navailles S, De Deurwaerdère P, Ugedo L.

Br J Pharmacol. 2016 Jul;173(13):2135-46. doi: 10.1111/bph.13447. Epub 2016 Mar 8.

23.

New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders.

Di Giovanni G, De Deurwaerdère P.

Pharmacol Ther. 2016 Jan;157:125-62. doi: 10.1016/j.pharmthera.2015.11.009. Epub 2015 Nov 23. Review.

PMID:
26617215
24.

Early prenatal exposure to MPTP does not affect nigrostrial neurons in macaque monkey.

Bourdenx M, Dovero S, De Deurwaerdère P, Li Q, Bezard E.

Synapse. 2016 Feb;70(2):52-6. doi: 10.1002/syn.21876. Epub 2015 Dec 4.

PMID:
26584009
25.

The impact of combined administration of paraquat and maneb on motor and non-motor functions in the rat.

Tinakoua A, Bouabid S, Faggiani E, De Deurwaerdère P, Lakhdar-Ghazal N, Benazzouz A.

Neuroscience. 2015 Dec 17;311:118-29. doi: 10.1016/j.neuroscience.2015.10.021. Epub 2015 Oct 20.

PMID:
26477982
26.

Monoamine content during the reproductive cycle of Perna perna depends on site of origin on the Atlantic Coast of Morocco.

Klouche MS, De Deurwaerdère P, Dellu-Hagedorn F, Lakhdar-Ghazal N, Benomar S.

Sci Rep. 2015 Sep 9;5:13715. doi: 10.1038/srep13715.

27.

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.

Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bézard E.

Prog Neurobiol. 2015 Sep;132:96-168. doi: 10.1016/j.pneurobio.2015.07.002. Epub 2015 Jul 21. Review.

PMID:
26209473
28.

The 5-HT4 Agonist Prucalopride Stimulates L-DOPA-Induced Dopamine Release in Restricted Brain Regions of the Hemiparkinsonian Rat In Vivo.

Navailles S, Di Giovanni G, De Deurwaerdère P.

CNS Neurosci Ther. 2015 Sep;21(9):745-7. doi: 10.1111/cns.12436. Epub 2015 Jul 24. No abstract available.

PMID:
26205756
29.

Serotonin, but not dopamine, controls the stress response and anxiety-like behavior in the crayfish Procambarus clarkii.

Fossat P, Bacqué-Cazenave J, De Deurwaerdère P, Cattaert D, Delbecque JP.

J Exp Biol. 2015 Sep;218(Pt 17):2745-52. doi: 10.1242/jeb.120550. Epub 2015 Jul 2.

30.

Blood withdrawal affects iron store dynamics in primates with consequences on monoaminergic system function.

Hyacinthe C, De Deurwaerdere P, Thiollier T, Li Q, Bezard E, Ghorayeb I.

Neuroscience. 2015 Apr 2;290:621-35. doi: 10.1016/j.neuroscience.2015.01.057. Epub 2015 Feb 4.

PMID:
25662508
31.

Prefronto-subcortical imbalance characterizes poor decision-making: neurochemical and neural functional evidences in rats.

Fitoussi A, Le Moine C, De Deurwaerdère P, Laqui M, Rivalan M, Cador M, Dellu-Hagedorn F.

Brain Struct Funct. 2015 Nov;220(6):3485-96. doi: 10.1007/s00429-014-0868-8. Epub 2014 Aug 19.

PMID:
25134683
32.

Monoaminergic control of spinal locomotor networks in SOD1G93A newborn mice.

Milan L, Barrière G, De Deurwaerdère P, Cazalets JR, Bertrand SS.

Front Neural Circuits. 2014 Jul 4;8:77. doi: 10.3389/fncir.2014.00077. eCollection 2014.

33.

Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats.

Orban G, Bombardi C, Marino Gammazza A, Colangeli R, Pierucci M, Pomara C, Pessia M, Bucchieri F, Benigno A, Smolders I, De Deurwaerdère P, Di Giovanni G.

CNS Neurosci Ther. 2014 Jul;20(7):651-61. doi: 10.1111/cns.12285. Erratum in: CNS Neurosci Ther. 2014 Oct;20(10):950. Arcangelo, Benigno [corrected to Benigno, Arcangelo].

PMID:
24935789
34.

Comparative behavior. Anxiety-like behavior in crayfish is controlled by serotonin.

Fossat P, Bacqué-Cazenave J, De Deurwaerdère P, Delbecque JP, Cattaert D.

Science. 2014 Jun 13;344(6189):1293-7. doi: 10.1126/science.1248811.

35.

Manganese-induced atypical parkinsonism is associated with altered Basal Ganglia activity and changes in tissue levels of monoamines in the rat.

Bouabid S, Delaville C, De Deurwaerdère P, Lakhdar-Ghazal N, Benazzouz A.

PLoS One. 2014 Jun 4;9(6):e98952. doi: 10.1371/journal.pone.0098952. eCollection 2014.

36.

NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.

El Arfani A, Bentea E, Aourz N, Ampe B, De Deurwaerdère P, Van Eeckhaut A, Massie A, Sarre S, Smolders I, Michotte Y.

Neuropharmacology. 2014 Oct;85:198-205. doi: 10.1016/j.neuropharm.2014.05.024. Epub 2014 May 24.

PMID:
24863042
37.

N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties.

Di Giovanni G, García I, Colangeli R, Pierucci M, Rivadulla ML, Soriano E, Chioua M, Della Corte L, Yáñez M, De Deurwaerdère P, Fall Y, Marco-Contelles J.

CNS Neurosci Ther. 2014 Jul;20(7):633-40. doi: 10.1111/cns.12284. Epub 2014 May 21.

PMID:
24848125
38.

Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats.

Navailles S, Milan L, Khalki H, Di Giovanni G, Lagière M, De Deurwaerdère P.

CNS Neurosci Ther. 2014 Jul;20(7):671-8. doi: 10.1111/cns.12275. Epub 2014 Apr 28.

PMID:
24775184
39.

Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia.

Engeln M, De Deurwaerdère P, Li Q, Bezard E, Fernagut PO.

Cereb Cortex. 2015 Sep;25(9):2783-92. doi: 10.1093/cercor/bhu076. Epub 2014 Apr 25.

PMID:
24770706
40.

Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.

Navailles S, Di Giovanni G, De Deurwaerdère P.

CNS Neurosci Ther. 2014 Jul;20(7):699-701. doi: 10.1111/cns.12252. Epub 2014 Mar 15. Review. No abstract available.

PMID:
24628826
41.

L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum.

Porras G, De Deurwaerdere P, Li Q, Marti M, Morgenstern R, Sohr R, Bezard E, Morari M, Meissner WG.

Sci Rep. 2014 Jan 16;4:3730. doi: 10.1038/srep03730.

42.

Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition.

Fitoussi A, Dellu-Hagedorn F, De Deurwaerdère P.

Neuroscience. 2013;255:233-45. doi: 10.1016/j.neuroscience.2013.09.059. Epub 2013 Oct 10.

PMID:
24120557
43.

Catecholamine/Serotonin interactions: systems thinking for brain function and disease.

Hensler JG, Artigas F, Bortolozzi A, Daws LC, De Deurwaerdère P, Milan L, Navailles S, Koek W.

Adv Pharmacol. 2013;68:167-97. doi: 10.1016/B978-0-12-411512-5.00009-9. Review.

44.

Role of 5-HT2C receptors in the enhancement of c-Fos expression induced by a 5-HT2B/2C inverse agonist and 5-HT 2 agonists in the rat basal ganglia.

Navailles S, Lagière M, Le Moine C, De Deurwaerdère P.

Exp Brain Res. 2013 Oct;230(4):525-35. doi: 10.1007/s00221-013-3562-9. Epub 2013 May 17.

PMID:
23681297
45.

Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.

De Deurwaerdère P, Lagière M, Bosc M, Navailles S.

Exp Brain Res. 2013 Oct;230(4):477-511. doi: 10.1007/s00221-013-3508-2. Epub 2013 Apr 25. Review.

PMID:
23615975
46.

A tobacco extract containing alkaloids induces distinct effects compared to pure nicotine on dopamine release in the rat.

Khalki H, Navailles S, Piron CL, De Deurwaerdère P.

Neurosci Lett. 2013 Jun 7;544:85-8. doi: 10.1016/j.neulet.2013.03.047. Epub 2013 Apr 9.

PMID:
23583588
47.

Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain.

Navailles S, Lagière M, Contini A, De Deurwaerdère P.

ACS Chem Neurosci. 2013 May 15;4(5):680-92. doi: 10.1021/cn400046e. Epub 2013 Apr 15. Review.

48.

The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.

Lagière M, Navailles S, Mignon L, Roumegous A, Chesselet MF, De Deurwaerdère P.

Exp Brain Res. 2013 Oct;230(4):513-24. doi: 10.1007/s00221-013-3478-4. Epub 2013 Mar 28.

PMID:
23535834
49.

Serotonin2c receptor constitutive activity: in vivo direct and indirect evidence and functional significance.

Navailles S, Lagière M, Guthrie M, De Deurwaerdère P.

Cent Nerv Syst Agents Med Chem. 2013 Jun;13(2):98-107. Review.

PMID:
23441866
50.

Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat.

Abedi PM, Delaville C, De Deurwaerdère P, Benjelloun W, Benazzouz A.

Neuroscience. 2013 Apr 16;236:289-97. doi: 10.1016/j.neuroscience.2013.01.043. Epub 2013 Jan 30.

PMID:
23376117

Supplemental Content

Loading ...
Support Center